Patent ID: 8026281

Claim:
A method for treating metabolic syndrome in a human, the method comprising: administering a therapeutically effective amount of fenofibrate to a human having metabolic syndrome, wherein a human has metabolic syndrome if the human has at least three characteristics selected from the group consisting of: (a) a waist circumference greater than 102 cm for men and greater than 88 cm for women; (b) a triglyceride level greater than 150 mg/dl; (c) an HDL-cholesterol level less than 40 mg/dl for men and less than 50 mg/dl for women; (d) a blood pressure greater than or equal to 130/85 mmHG; and (e) a fasting glucose level greater than 110 mg/dl, such that after said administering of fenofibrate the human no longer has at least three characteristics selected from the group consisting of (a), (b), (c), (d), and (e).